176 related articles for article (PubMed ID: 20797971)
1. In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009.
Rowe T; Banner D; Farooqui A; Ng DC; Kelvin AA; Rubino S; Huang SS; Fang Y; Kelvin DJ
J Gen Virol; 2010 Dec; 91(Pt 12):2898-906. PubMed ID: 20797971
[TBL] [Abstract][Full Text] [Related]
2. [In vitro and in vivo anti-influenza virus activity of ribavirin injection].
Gao RM; Li XQ; He WY; Jiang JD; Li YH
Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
Chen L; Dou J; Su Z; Zhou H; Wang H; Zhou W; Guo Q; Zhou C
Antiviral Res; 2011 Sep; 91(3):314-20. PubMed ID: 21782851
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
[TBL] [Abstract][Full Text] [Related]
5. An improved embryonated chicken egg model for the evaluation of antiviral drugs against influenza A virus.
Wang JX; Zhou JY; Yang QW; Chen Y; Li X; Piao YA; Li HY
J Virol Methods; 2008 Nov; 153(2):218-22. PubMed ID: 18652846
[TBL] [Abstract][Full Text] [Related]
6. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Smee DF; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
[TBL] [Abstract][Full Text] [Related]
7. Anti-influenza virus effects of the aqueous extract from Mosla scabra.
Yu C; Yan Y; Wu X; Zhang B; Wang W; Wu Q
J Ethnopharmacol; 2010 Feb; 127(2):280-5. PubMed ID: 19914366
[TBL] [Abstract][Full Text] [Related]
8. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
9. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
Jiang T; Zhao H; Li XF; Deng YQ; Liu J; Xu LJ; Han JF; Cao RY; Qin ED; Qin CF
Antiviral Res; 2011 Jan; 89(1):124-6. PubMed ID: 21115063
[TBL] [Abstract][Full Text] [Related]
10. Effects of TheraMax on influenza virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
12. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.
Droebner K; Pleschka S; Ludwig S; Planz O
Antiviral Res; 2011 Nov; 92(2):195-203. PubMed ID: 21854809
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
[TBL] [Abstract][Full Text] [Related]
15. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
[TBL] [Abstract][Full Text] [Related]
16. Anti-influenza-virus activity of total alkaloids from Commelina communis L.
Bing FH; Liu J; Li Z; Zhang GB; Liao YF; Li J; Dong CY
Arch Virol; 2009; 154(11):1837-40. PubMed ID: 19774337
[TBL] [Abstract][Full Text] [Related]
17. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
Belser JA; Szretter KJ; Katz JM; Tumpey TM
Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.
Murray JL; McDonald NJ; Sheng J; Shaw MW; Hodge TW; Rubin DH; O'Brien WA; Smee DF
Antivir Chem Chemother; 2012 May; 22(5):205-15. PubMed ID: 22374988
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
Barnard DL; Wong MH; Bailey K; Day CW; Sidwell RW; Hickok SS; Hall TJ
Antivir Chem Chemother; 2007; 18(3):125-32. PubMed ID: 17626596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
